Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety in Micafungin Sodium for Prophylaxis Against Invasive Fungal Disease During Neutropenia in Pediatric & Adolescent Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT01135589 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01135589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01135589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety in Micafungin Sodium for Prophylaxis Against Invasive Fungal Disease During Neutropenia in Pediatric & Adolescent Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2010
Completion date
May 31, 2012
Enrollment
145 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation, invasive fungal disease, neutropenia